having regard to the Council conclusions of 17 June 2016 on strengthening the balance in the pharmaceutical systems in the EU and its Member States,
ob upoštevanju sklepov Sveta z dne 17. junija 2016 o krepitvi ravnovesja v farmacevtskih sistemih v EU in njenih državah članicah,